Uppsala, Sweden

Johan William Ohman

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations and Contributions of Johan William Ohman

Introduction

Johan William Ohman is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of chromatography and protein analysis, holding a total of five patents. His work has advanced the understanding and application of protein affinity chromatography resins and methods for protein analysis.

Latest Patents

Ohman's latest patents include "Chromatography resin, production and use thereof," which focuses on producing protein affinity chromatography resins that utilize affinity ligands based on a N-terminal fragment of a split intein, such as DnaE. This invention details methods for producing these fragments in inclusion bodies within bacterial cells. Another significant patent is the "Method for protein analysis," which provides innovative methods for analyzing proteins displayed on discrete and dispersible structures, such as beads or particles, facilitating subsequent affinity reactions and analysis.

Career Highlights

Throughout his career, Johan William Ohman has worked with prominent companies in the biotechnology sector, including GE Healthcare Bio-Sciences AB and Cytiva Bioprocess R&D AB. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in bioprocessing and protein analysis.

Collaborations

Ohman has collaborated with several professionals in his field, including Camilla Estmer Nilsson and Therese Graner. These collaborations have likely enriched his research and development efforts, fostering innovation in his projects.

Conclusion

Johan William Ohman is a distinguished inventor whose work in chromatography and protein analysis has led to significant advancements in the field. His patents and collaborations reflect his commitment to innovation and excellence in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…